NICE recommends eltrombopag for patients with ITP
The National Institute for Clinical Excellence (NICE) has recommended eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpurai (ITP).
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units